img
Peanut induced anaphylaxis in children and adolescents: Data from the European Anaphylaxis Registry   
Yazarlar
Ioana Maris
Sabine Doelle-Bierke
Jean-Marie Renaudin
Lars Lange
Alice Koehli
Thomas Spindler
Jonathan Hourihane
Kathrin Scherer
Katja Nemat
C. Kemen
Irena Neustaedter
Christian Vogelberg
Thomas Reese
Dr. Öğr. Üyesi İsmail YILDIZ Dr. Öğr. Üyesi İsmail YILDIZ
Kastamonu Üniversitesi
Zsolt Szepfalusi
Hagen Ott
Helen Straube
Nikolaos G. Papadopoulos
Susanne Haemmerling
Ute Staden
Michael Polz
Tihomir Mustakov
Ewa Cichocka-Jarosz
Renata Cocco
Alessandro Giovanni Fiocchi
Montserrat Fernandez-Rivas
Margitta Worm
Özet
Peanut allergy has a rising prevalence in high-income countries, affecting 0.5%-1.4% of children. This study aimed to better understand peanut anaphylaxis in comparison to anaphylaxis to other food triggers in European children and adolescents. Data was sourced from the European Anaphylaxis Registry via an online questionnaire, after in-depth review of food-induced anaphylaxis cases in a tertiary paediatric allergy centre. 3514 cases of food anaphylaxis were reported between July 2007 - March 2018, 56% in patients younger than 18 years. Peanut anaphylaxis was recorded in 459 children and adolescents (85% of all peanut anaphylaxis cases). Previous reactions (42% vs. 38%; p = .001), asthma comorbidity (47% vs. 35%; p < .001), relevant cofactors (29% vs. 22%; p = .004) and biphasic reactions (10% vs. 4%; p = .001) were more commonly reported in peanut anaphylaxis. Most cases were labelled as severe anaphylaxis (Ring&Messmer grade III 65% vs. 56% and grade IV 1.1% vs. 0.9%; p = .001). Self-administration of intramuscular adrenaline was low (17% vs. 15%), professional adrenaline administration was higher in non-peanut food anaphylaxis (34% vs. 26%; p = .003). Hospitalization was higher for peanut anaphylaxis (67% vs. 54%; p = .004). The European Anaphylaxis Registry data confirmed peanut as one of the major causes of severe, potentially life-threatening allergic reactions in European children, with some characteristic features e.g., presence of asthma comorbidity and increased rate of biphasic reactions. Usage of intramuscular adrenaline as first-line treatment is low and needs to be improved. The Registry, designed as the largest database on anaphylaxis, allows continuous assessment of this condition.
Anahtar Kelimeler
anaphylaxis | food allergy | paediatrics
Makale Türü Özgün Makale
Makale Alt Türü ESCI dergilerinde yayımlanan tam makale
Dergi Adı ALLERGY
Dergi ISSN 0105-4538
Makale Dili İngilizce
Basım Tarihi 05-2021
Cilt No 76
Sayı 5
Sayfalar 1517 / 1527
Doi Numarası 10.1111/all.14683